Biosimilars
Business
Swiss Generic Drugmaker Sandoz Lowered its Full-Year Sales Growth
Sandoz shares fell over 5% after the drugmaker lowered its 2026 sales growth forecast, despite raising its core earnings margin outlook.
Business
Swiss vs Indian Pharma: The Home & The Supplier Of Pharmaceuticals
Explore the differences between Swiss and Indian pharmaceutical industries, from research-driven medicines to affordable generics and global market competition.
